Search

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

… Thursday, July 28, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Ya-Ting Wang and Inaki Etxberria Ya-Ting “Emma” Wang and Inaki Etxberria Receive Prestigious Early Career Researcher Awards Ya-Ting “Emma” Wang , postdoctoral fellow, was named the 2022

… Monday, December 27, 2021 Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK) and the Chinese Thoracic Oncology Group (CTONG), an alliance of more than 30 premier academic cancer centers in China – joined

Learn how testicular cancer is often misunderstood and why it is highly treatable.

… Thursday, June 29, 2023 Highlights Testicular cancer Testicular cancer is a rare but very curable disease. Testicular cancer strikes younger men (people whose sex assigned at birth was male). An injury to your testicles (getting “hit in the balls”) does not cause testicular cancer.   Many people with

Read about a new treatment for people with some ER+, HER2- advanced breast cancers.

… Friday, December 12, 2025 Updated results from a clinical trial show that a new treatment continues to be effective at stopping advanced breast cancer from progressing in some people with tumors that have grown resistant to standard therapy. The new data also suggests that overall survival can be improved

… Tuesday, September 3, 2024 Dear MSK Community, Our knowledge of cancer — what it is and how it progresses — has developed at a staggering pace over the past 20 years. Today, thanks to remarkable advances in the understanding of how cancer cells behave and evolve, many led by MSK, researchers have devised

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

… Wednesday, April 27, 2022 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Jorge S. Reis-Filho Named a Susan G. Komen Scholar Jorge S. Reis-Filho Jorge S. Reis-Filho, MD, PhD, FRCPath, Chief, Experimental Pathology Service, was named a Susan G. Komen Scholar

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ancestries, according to new MSK research. This trend could exacerbate disparities in cancer outcomes.

… Thursday, January 9, 2025 Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century have received that approval based on their ability to target genetic changes driving tumor growth. Medical oncologists use information about the genetic

Researchers from Memorial Sloan Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer.

… Friday, July 12, 2013 Researchers from Memorial Sloan Kettering Cancer Center recently discovered that the most frequently used cancer cell lines in ovarian cancer research are not suitable models of ovarian cancer. Their findings are the result of a detailed review of genomic data that recently became

The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.

… Monday, July 1, 2019 Summary MSK researchers have made new discoveries about how changes in a family of cancer-causing genes can lead to epigenetic changes. A family of genes called IDH are associated with cancer. These genes make enzymes called isocitrate dehydrogenases. The enzymes help break down

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.

… Thursday, December 12, 2013 Summary Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer. Sometimes a medical treatment becomes the standard of care before experts are able to explain